The design and synthesis of a phthalocyanine -Gd-DOTA conjugate is presented to open the way to novel molecular theranostics, combining the properties of MRI contrast imaging with photodynamic therapy. The rational design of the conjugate integrates isomeric purity of the phthalocyanine core substitution, suitable biocompatibility with the use of polyoxo water-solubilizing substituents, and a convergent synthetic strategy ended by the use of click chemistry to graft the Gd-DOTA moiety to the phthalocyanine. Photophysical and photochemical properties, contrast imaging experiments and preliminary in vitro investigations proved that such a combination is relevant and lead to a new type of potential theranostic agent.
INTRODUCTION
Theranostics is one of the promising ways to personalized medicine, more especially against cancer, combining diagnostic and therapeutic effects (1, 2) . Most of theranostics are nanoobjects as they allow easily combining the different features required (3), when molecular theranostics are rather rare due to the difficulty of combining several properties and effects in a unique chemical derivative. Since the premises of modern photodynamic therapy, the drawbacks of the first-generation of photosensitizers, mainly due to their polymeric poorly characterizable structures have been overcome by the development of second-generation of photosensitizers, consisting mainly of molecular tetrapyrroles of well-defined structures and tailorable properties (4) . The third generation of photosensitizers combines imaging agents and photosensitizers to have the patient benefiting from a "see and treat" process (5) , and theranostics quickly took place in the photodynamic therapy field. Among the different types of photosensitizers, porphyrins (6) and phthalocyanines (7, 8) are particularly employed. Zn(II) phthalocyanines offer the advantage of its nearinfra red absorption, centered at 700 nm and adjustable by playing on the substitution pattern (9, 10) . Near-infrared red absorption has the double advantage of a deeper penetration of the light into tissues, and to fit the biological therapeutic window a biological components does not absorb at these wavelengths. Besides, phthalocyanines are extremely stable, compared for example to chlorins absorbing at similar wavelengths but less photostable (11) . A wide range of nanoparticles has been reported (12) (13) (14) (15) , when only a few examples of molecular theranostic for PDT are described (16, 17) . In most cases, imaging properties are fluorescence-based, phthalocyanines being intrinsically good fluorescent probes (18) . Nevertheless, labeling of porphyrins and phthalocyanines by radioelements (19) , such as 18 Fradiolabeling for PET imaging is reported (20) .
Nowadays, computer tomography is the most common imaging technique, PET being the most common for tumors. Contrast magnetic resonance imaging (MRI) is an imaging modality accessible in radiological practice, particularly for the identification and characterization of delicate tissue pathologies, especially solid tumors in cancer, as a non-invasive diagnostic imaging technique utilized within clinical and biomedical examination. The affectability and specificity, and consequently differentiation of MR images, might be further upgraded by the utilization of responsive contrast agents. The majority of MRI contrast agents are paramagnetic complexes made of cyclen-based chelates of lanthanide ions, generally gadolinium (Gd 3+ )-based chelates (21) (22) (23) . A wide sort of paramagnetic chelates based on Gd(III), have been contrived as T 1 contrast agents (positive contrast agents) to create a large magnetic moment. Such complexes are known to exhibit nephrotoxic effects (24) . This prompts researchers to direct their efforts toward new imaging techniques. These effects are still balanced by their powerful imaging properties. At present, Gd-based contrast agents have been employed in >40% of MRI scans, acting an important role in contrast enhanced MRI studies (25) (26) (27) (28) . Diethylene triamine pentaacetic acid Gd complexes are the most widely used ones, as is the commercially available Magnevist â , Omniscan â being a bismethylamide substituted diethylene triamine pentaacetic acid Gd complex (29) . The efficacy of these contrast agents depends on the interchanging of water between the bulk solvent and the coordination sphere. The swapping scale of bound water relies upon nature of the ligand and the metal ion. Complexes made with the chelator DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) exhibit the fastest rate of bound water. For the last several years, our laboratory has focused its research on developing NIR absorbing photosensitizers with a phthalocyanine core (30) (31) (32) (33) (34) , with enhanced efficacy thanks to various strategies: targeting (35) , dual antivascular action (36, 37) , nanoparticles functionalization (38, 39) . We then wished to explore the possibility to produce PDT sensitizers having MRI contrast imaging properties, to enlarge the range of available techniques for dual imaging and photosensitization, and obtain a novel type of theranostic agent. We selected a DOTA unit complexing a gadolinium atom as the MRI contrast agent, coupled to a Zn phthalocyanine core with known photosensitizing properties. To our knowledge, such strategy has not been developed yet: the only DOTA-phthalocyanine conjugate reported so far includes 68 Ga to be used as PET/fluorescent dual imaging probe (40) .
In this paper, we report the design and the synthesis as well as the theranostic dual photodynamic and imaging potential of the phthalocyanine-GdDOTA conjugate 8. 13 C). Normal resolution mass spectra were recorded on a LCQ-ion trap (Thermo Finnigan, San Jose, CA), equipped with an ES (Electrospray) ionization source. High-resolution MALDI spectra for 6 and 8 were obtained as follows: the matrix solution was 20 mg mL À1 2,5-dihydroxy benzoic acid (DHB) in 30% acetonitrile/70% aqueous 0.1% trifluoroacetic acid (v/v) for measuring conjugate 8. Sample was dissolved in Milli-Q water and one lL was mixed with 1 lL of matrix. One lL of the resulting mixture was spotted on the MTP 384 polished steel plate. Sample was allowed to air dry and crystallizes before the target was loaded into the mass spectrometer. Mass spectra were obtained in positive reflectron ion mode using Autoflex Speed MALDI-TOF mass spectrometer (Bruker Daltonics, Bremen, Germany) with an acceleration voltage of 19 kV and laser frequency of 1 Hz. The laser power was set at 40% to 100% of the maximum. Signals from 500 shots were accumulated for each spectrum. For external calibration the standard peptide mixture "Peptide Mix II" (Bruker Daltonics) was used. ICP-MS was performed on Thermo X series II. Each sample was acquired using 1 survey run (10 sweeps) and 3 main (peak jumping) runs (100 sweeps). The isotopes selected were 156, 157 Gd for acquisition, with 115 In, 165 Ho and 209 Bi as internal standards for data interpolation and machine stability. Conjugate 8 (1 mg) was dissolved in concentrated nitric acid (1 mL) and sonicated for 15 min. After appropriate dilution in 5% aq. HNO 3 solution (v/ v %) samples were fed to ICP-mass spectrometer. Ratio of Zn to Gd metal ions was calculated based on obtained concentration values. IR spectra were recorded on a Perkin Elmer 100 FTIR spectrometer. All solvents and chemicals were of reagent-grade quality, purchased from Sigma-Aldrich Chemical Co. and Merck, and used as received. 1,3-diphenylisobenzofuran (DPBF) was purchased from Fluka. Unless otherwise indicated, organic extracts were dried over anhydrous sodium sulfate and concentrated under reduced pressure using a rotary evaporator. Purification by column chromatography was performed using Merck Kieselgel 60 silica gel as the stationary phase. Ultra-pure water was obtained from a Milli-Q Water System (Sartorius arium 611 UV). 4,5-bis(4,7, 10-trioxaundecane1-sulfonyl)phthalonitrile (41), 4-(carboxyethylsulphanyl) phthalonitrile 2 (42), 3-azido-aminopropylamine (43) and Gd(III) derivatives (Gd-595 MW 595 g mol À1 ) (44, 45) were synthesized according to previously described procedures.
MATERIALS AND METHODS
Syntheses. Synthesis of N-(3-azidopropyl)-3-((3,4-dicyanophenyl)thio) propanamide (4). 4-Carboxyethylsulfanyl phthalonitrile 2 (300 mg, 1.3 mmol) was dissolved in anhydrous THF (5 mL) under argon atmosphere, then thionyl chloride (1.6 g, 13.3 mmol) in anhydrous toluene (5 mL) was added and the solution was refluxed for 3 h. Thereafter, solvents and excess of thionyl chloride were evaporated under reduce pressure. Brown oil was dissolved in anhydrous THF (5 mL) and 1-azido-3-aminopropane 3 (390 mg, 3.9 mmol) (as a free base) in anhydrous THF (5 mL) was added slowly drop by drop, then the mixture was refluxed for 3 h. The crude product was concentrated under reduce pressure, suspended in water and extracted three times with ethyl acetate. Organic layer was then extracted with brine, dried over anhydrous Na 2 SO 4 and purified by column chromatography on silica with dichloromethane/ethyl acetate 100:1 as eluent followed by recrystallization from ethanol yielding yellowish solid (280 mg, 68% (6) . N-(3-azidopropyl)-3-((3,4-dicyanophenyl)thio)propanamide 4 (50 mg, 0.16 mmol) and 4,5-bis(4,7,10-trioxaundecane-1-sulfonyl) phthalonitrile 1 (670 mg, 1.44 mmol) were dissolved in anhydrous dimethylaminoethanol (2 mL) under argon atmosphere and stirred for 20 min. Then Zn(OAc) 2 (150 mg, 0.80 mmol) was added and solution was refluxed for further 1 h at 120°C, then the reaction was cooled down. The reaction mixture was evaporated under reduce pressure. A crude green mixture of symmetric derivative 5 and desired asymmetric derivative 6 was purified by column chromatography over bio-beads using CH 2 Cl 2 as eluent, then the two derivatives were separated on preparative silica gel TLC using CH 2 X-ray data collection and structure refinement. Unit cell measurements and intensity data collection were performed on an Bruker APEX II QUAZAR three-circle diffractometer using monochromatized Mo Ka X-radiation (k = 0.71073 A) using φ and x technique. Indexing was performed using APEX2 (46) . Data integration and reduction were carried out with SAINT V8.27B (47) . Absorption correction was performed by multiscan method implemented in SADABS V2012/1 (48). The structure was solved using the direct methods procedure in SHEL-XS-97 (49) and then refined by full-matrix least-squares refinements on F2 using the SHELXL-97. All non-hydrogen atoms were refined anisotropically using all reflections with I > 2r(I). C-bound H-atoms were positioned geometrically and refined using a riding mode. The N-bound H atom was located from the difference Fourier map and restrained to be 0.89 A from N atom using DFIX and its position was constrained to refine on its parent N atom with Uiso(H) = 1.2 Ueq(N). Crystallographic data and refinement details of the data collection for 4 are given in Table S1 . The final geometrical calculations and the molecular drawings were carried out with Platon v1.16 (50) and Mercury CSD 3.1 program (51).
EPR measurements. The solution EPR spectrum was recorded in solution (chloroform) with a Jeol JES FA 300 X-bandspectrometer (8.96 GHz) with about 1mW microwave power and 100 kHz magnetic field modulation, at room temperature.
Photophysics and photochemistry. Instrumentation. Absorption spectra in the UV-Visible region were recorded with a Shimadzu 2001 UV spectrophotometer. Fluorescence excitation and emission spectra were recorded on a Varian Eclipse spectrofluorometer using 1 cm pathlength cuvettes at room temperature. Photo-irradiations were done using a General Electric quartz line lamp (300W). A 600 nm glass cut off filter (Schott) and a water filter were used to filter off ultraviolet and infrared radiations respectively. An interference filter (Intor, 700 nm with a band width of 40 nm) was additionally placed in the light path before the sample. Light intensities were measured with a POWER MAX5100 (Molelectron detector incorporated) power meter.
Fluorescence quantum yield determination. Fluorescence quantum yield (Φ F ) was estimated by the comparative method (Eq. 1) (52,53) using unsubstituted Zn(II) phthalocyanine (ZnPc) as the reference. Reference value of Φ F is 0.18 in DMSO for ZnPc (54) U F ¼ U Singlet oxygen quantum yield determination. Singlet oxygen quantum yield (Φ D ) was determined in air using the relative method (55) with ZnPc (in DMSO) or ZnPcSmix (in aqueous media) as the reference. DPBF (1,3-diphenylisobenzofuran) and ADMA (anthracene-9,10-bismethylmalonate) were used as chemical quencher for singlet oxygen, respectively in DMSO and aqueous media, using Eq. and are the rates of light absorption by the sample and standards, respectively. To avoid chain reactions induced by the initial photo-oxidative product of the reaction between DPBF (or ADMA) and singlet oxygen (56) , the concentration of quenchers (DPBF or ADMA) was lowered tõ 3 9 10 À5 M. Solutions of the photosensitizer containing DPBF (or ADMA) were prepared in the dark and irradiated in the Q-band region using the setup described in equipment part. DPBF degradation at 417 nm and ADMA degradation at 380 nm (in water) were monitored. The light intensity of 7.05 9 10 15 photons s À1 cm À2 was used for Φ D determinations.
Photodegradation quantum yield determination. Photodegradation quantum yield (Φ d ) determination was carried out using the experimental setup described in literature (57, 58) . Φ d value was determined using Eq. (3),
where C 0 and C t are respectively the sample concentrations before and after irradiation, V is the reaction volume, N A the Avogadro's constant, S the irradiated cell area and t the irradiation time, I abs is the overlap integral of the radiation source light intensity and the absorption of the sample. A light intensity of 2.20 9 10 16 photons s À1 cm À2 was employed for Φ d determinations.
Relaxivity (r 1 ) measurements. MRI relaxivity measurements were performed on a Siemens 3T TIMTrio Scanner (Siemens Medical Solutions, Erlangen, Germany) at 37°C. The presence of paramagnetic Gd(III) in the complexes resulted in an enhancement of the longitudinal relaxation rate of water protons (1/T1). Aqueous solutions of Gd(III) complexes were prepared at various concentrations (0.05, 0.10, 0.20, 0.40, 0.80 and 1.60 mM). A 3 mL glass sample holder (d = 10 mm) was placed in the isocenter of the magnet. Spin-echo pulse sequences with multiple spin echoes of various repetition times were utilized to obtain pixel-by-pixel T1 maps of each sample. T1 relaxation times were measured from large regions of interest and results were inverted to obtain the R 1 (1/T 1 ) relaxation rate in s 
The inverse of the longitudinal relaxation time (R 1 , s À1 ) was plotted against Gd(III) complex concentration (mM) and fitted to a straight line with R 2 > 0.99. The slope of the fitted line was taken as the relaxivity (r 1 , mM À1 s À1 ). Cell viability. Human breast adenocarcinoma cells (MCF-7) were grown to confluence at 37°C under 5% CO 2 in Dulbecco's Modified Eagle Serum (DMEM) containing 1% penicillin/streptomycin, 10% fetal bovine serum (FBS) and 2 mM L-glutamine. The cells were seeded in 96-well plates at an initial density of 1 9 10 4 cells/well. 24 h after cell seeding, phthalocyanine complex was added to final concentrations of 1, 5, 10, 20 and 50 lM, respectively (n = 4). After 24 h, 48 h and 72 h incubation, viability of cells was evaluated by using Alamar blue assay according to manufacturer's instructions. SpectraMax M5 microplate reader (Molecular Devices) was used for analysis.
Confocal microscopy. MCF-7 cells were seeded in 24-well plates at an initial cell density of 5 9 103 cells/well. After 24 h incubation period, the cells were treated with 10 lM conjugate 8 at 37°C for 24 h in a humidified chamber with 5% CO 2 . After 24 h, cells were washed three times with phosphate-buffered saline (PBS), fixed with 4% paraformaldehyde in PBS, covered with mounting medium and coverslip and stored at À20°C. The samples were imaged with Zeiss LSM-510 confocal microscope with an oil-immersion 639 objective lens. An argon laser of 488 nm wavelength was used.
RESULTS AND DISCUSSION

Synthesis and characterizations
On a molecular design point of view, A3B substitution pattern of the phthalocyanine appeared to be the best, one isoindole subunit bearing the DOTA unit and the three other isoindole subunits bearing biocompatible water-solubilizing moieties. The design of such a conjugate and this choice of the A3B substitution pattern, in which one phthalocyanine core is coupled to one Gd-DOTA unit, takes into account the working concentrations in both thera-peutic methods, which are both compatible in the micromolecular range (59) .
Common drawbacks of phthalocyanines are the regioisomeric mixtures and their important aggregation tendency due to pistacking opportunity between two macrocycles, often enhanced in water. Polyethylene glycol substitution was proved to be a good substitution pattern for photosensitizing phthalocyanines (30, 31) . To avoid regioisomeric mixtures detrimental to further clinical tests, peripheral disubstitution pattern was selected, using thiol functionalized polyethylene glycol chains (30) . If free-base phthalocyanines exhibit good fluorescence, better singlet oxygen generation is observed when the phthalocyanine is coordinated to a metal or a pseudo-metal such as Zn(II), Al(III), Ga(III), Si(IV). Zn metalation is the most common and was selected for these works. The resulting complex designed here is a bimetallic molecule, the Gd-DOTA for the MRI effect and the Zn metalation of the phthalocyanine for the photodynamic activity.
The choice of the Gd-DOTA unit coupled to a phthalocyanine was likely to satisfy all our requirements for good imaging results: fast water exchange, tenable rotational dynamics and limited internal motion. The efficiency of a contrast agent is expressed by their relaxivity r 1 and a much higher effectiveness, achievable by tuning its physico-chemical characteristics: the residence time of the water molecule(s) coordinated to the central GdIII ion (sM) and the rotational correlation time of the whole molecule (sR). In general, the clinically used contrast agents have too slow water exchange rate (long sM) and too fast molecular tumbling (short sR) due to their low-molecular-weight nature. As it is known that increasing the molecular size of MRI imaging agent enhances its overall molecular relaxivity, the conjugation to phthalocyanine, which is a molecule of elevated molecular weight, is expected to have a beneficial effect on the imaging properties.
On a synthetic strategy aspect, the Huisgen dipolar addition of click chemistry is a powerful synthetic tool successfully used in tetrapyrrolic functionalization (60) and was selected for the coupling of the DOTA moiety onto the phthalocyanine. To click the known alkynyl DOTA 7 (known as Gd-595) (59), the azidofunctionalized phthalocyanine 6 was designed.
A3B phthalocyanines are easily obtained by cyclotetramerization reactions applied to a statistical mixture of two phthalonitriles. The first synthetic strategy envisaged was the preparation of a monocarboxylated phthalocyanine on which introduce the azido function (Scheme 1), but the purification and separation of the desired A3B from the concomitantly formed symmetric derivative proved to be tedious. The alternative synthetic strategy adopted was the preparation of an azidophthalonitrile, used to obtain an A3B azidophthalocyanine, a suitable building block for click chemistry with any molecule bearing a terminal alkyne, and clicked hereafter onto alkynyl DOTA 7.
Azidophthalonitrile 4 is a key intermediate, prepared from phthalonitrile 2, amidified with 3-azidopropylamine (43) using SOCl 2 in a reasonable 68% yield, and that could be crystallized from ethanol at room temperature via slow evaporation. ORTEP representation with atomic numbering scheme is shown in A 9:1 ratio of starting materials has been calculated to lead to the formation of a mixture of only two derivatives: the symmetric A4 and the desired A3B phthalocyanine. This 9:1 ratio was applied to a mixture of starting materials (phthalonitriles 1 and 4) which underwent mixed cyclotetramerization in the presence of zinc acetate in dimethylaminoethanol, and led to the symmetric phthalocyanine 5 (identified accordingly to our previous reports (30) and the desired AAAB phthalocyanine 6, separated by preparative thin layer chromatography. The absence of other derivatives (except traces of A2B2 isomers), together with the yield of 28% for the desired A3B phthalocyanine 6, is attributable to the excess of phthalonitrile 1 and is excellent for this kind of reaction (63, 64 S6 ).
The phthalocyanine-DOTA conjugate 8 was obtained by click chemistry. Various conditions were tested for the click reaction. Heating azidophthalocyanine 5 in DMF with alkynyl GdDOTA, copper sulfate and sodium ascorbate appeared to be the most suitable conditions, leading to the desired conjugate 8 in rather high yield (45%). Purification was nevertheless laborious, due to the polarity of the conjugate inducing its sticking to silica gel during chromatographic purifications. NMR spectroscopy is not suitable for paramagnetic compounds, which is the case of conjugate 8. Its structure was ascertained by FT-IR (Fig. S9) and MALDI spectroscopy at high resolution (Fig. 1) . The experimental and theoretical isotopic patterns obtained for 8 in high-resolution conditions are fitting each other, confirming the structure of desired compound 8 (Fig. 1) . The EPR spectrum of conjugate 8 in chloroform was recorded in the 0-8000 G range at room temperature (Fig. S11) . The broad peak at about g % 1.997 in the spectrum belongs to Gd 3+ (S = 7/2) ions, with a peak-to-peak linewidth, DH pp ffi 560 G. Since Gd 3+ ion is S-state paramagnetic ion, the orbital contribution becomes quenched, resulting in a long relaxation time. The other peaks are background signals from sample tube and cavity. Gd 3+ ion has a 4f 7 electronic configuration and 8 S 7/2 ground state. Due to zero orbital angular momentum, it is only the trivalent lanthanide whose EPR can be observed at room temperature. The relaxation mechanism of Gd 3+ complexes in solution is determined by zero field splitting (ZFS) which is caused by the exchange interactions between unpaired electron spins, giving rise to a very broad line. In addition, inductively coupled plasma mass spectrometry (ICP-MS) analysis was performed. This technique detects specifically metals and the Gd-to-Zn ratio was estimated to be ca. 1, confirming that one Gd-DOTA unit is present per Zn phthalocyanine core ( Fig. S12 and Table S2 ).
Photophysics and photochemistry
The photophysical and photochemical properties of the DOTAphthalocyanine conjugate 8 were investigated and compared with those of the corresponding symmetrically substituted phthalocyanine 5, used as the analogous reference without DOTA unit (30) . All the data commented below are summarized in Tables 1 and 2 .
Photophysical properties. The electronic absorption spectrum of conjugate 8 was measured in DMSO, DMF, DCM and H 2 O (Fig. 2, top) . One can notice that the solubility of the conjugate is wide ranged, from very polar solvents such as water, to much more hydrophobic dichloromethane. The presence of the DOTA on 8 significantly enhanced the water-solubility compared to reference symmetric phthalocyanine 5 (30) even if the conjugate is still aggregated as evidenced by the blueshifted position and large shape of its Q band. This watersolubility is a positive aspect for further biological experiments. The fact that this was due to aggregation was confirmed by the addition of Triton X-100, a surfactant known to inhibit aggregation in aqueous media (65) (66) (67) . Indeed, the sharpness of the Q band was restored upon its addition. As further photophysical and photochemical measurements need to be conducted on monomerized (nonaggregated) molecules, the aggregation behavior of 8 was studied in different solvents (Fig. 2, bottom) . The ground-state electronic absorption spectrum of 8 in DMSO shows characteristic absorption in the Q-band region. The spectrum of this molecule exhibits monomeric behavior evidenced by a single narrow Q band which is typical of nonaggregated metallated phthalocyanine complexes, and it was therefore decided to conduct the next photophysical and photochemical measurements in this solvent, as well as in water which is the closest to biological medium.
Fluorescence characterization of the conjugate 8 was performed. The fluorescence emission spectrum of 8 is a mirror image of the absorption spectra, which is itself similar to the excitation spectrum (Fig. 3) . Fluorescence quantum yield (Φ F ) of phthalocyanine-DOTA conjugate 8 in DMSO is given in Table 3 and has been determined using reported calculation methods (68) . This molecule does not fluoresce in water, most probably due to the aggregation described above. (79) As biological media are not simple water, and as we demonstrated in previous reports that phthalocyanines monomerize in the presence of biological membranes and other components (69) , the fluorescence emission of conjugate 8 (observed in other solvents) is likely to be an additional useful tool for tumor visualization or photosensitizer distribution monitoring. As the sum of the quantum yields cannot exceed 1, the rather low fluorescence quantum yields can be correlated to the high singlet oxygen generation yield: the excited singlet state of compound 8 is converted into the triplet state rather than returning to its fundamental state by fluorescence emission.
Photochemical properties. The singlet oxygen quantum yield (Φ D ) is a crucial photochemical parameter in PDT as it quantifies the ability of a photosensitizer to generate singlet oxygen. Φ D was determined by a comparative method based on the decomposition of DPBF in DMSO and ADMA in H 2 O. These molecules react instantaneously with singlet oxygen via a dipolar cycloaddition, and their absorption is quenched by this reaction. Therefore, the diminution of the absorption of DPBF in DMSO at 417 nm, and of ADMA in water at 380 nm, is directly proportional to the singlet oxygen generated upon irradiation (see measured spectrum examples in refs 9,31 and 65). The curves in DMSO and water are presented in Fig. 4 , the results are summarized in Table 2 .
Molecules which are not aggregated exhibit their maximum singlet oxygen generation capability, as it is the case of 8 in DMSO, in which its Φ D value is 0.67. The presence of the Gd-DOTA moiety has no consequence on the singlet oxygen generation ability of the phthalocyanine core, which is in the same range than the reference compound 5 (30) . Minimum values to be acknowledged as a suitable photosensitizer is above 0.5 (65) , therefore the photodynamic ability of conjugate 8 is satisfying. Φ D value in water for conjugate 8 is lower than that of in DMSO. This is due to the aggregation and to the quenching of singlet oxygen by water (65) . Rather than concluding than this may prevent the use of conjugate 8 in intracellular media, one should keep in mind that cells are complex organization is likely to positively modify the aggregation state of the photosensitizer: we demonstrated that in the presence of membrane, phthalocyanine aggregated in pure water becomes monomerized and recover its photodynamic efficiency (69) .
Degradation of the molecules under irradiation reflects their stability. Depending on targeted applications, different values are suitable. For photocatalysts, maximum photostability is required, when for biological photoapplications, intermediate photostability is preferred to limit risks of accumulative toxicity. Conjugate 8 and reference derivative 5 exhibited about similar stability with Φ d of the order of 10 À5 (Table 2) , with no influence of the presence of the DOTA unit. Here, the Φ d value found is about the same with zinc phthalocyanine derivatives that have been synthesized before (30) . Conjugate 8 is in the appropriate range for biological applications in both DMSO and H 2 O.
Contrast imaging
The efficiency of clinically used contrast agents is expressed by their relaxivity r 1 , mainly influenced by the residence time of the water molecule(s) coordinated to the central Gd(III) ion (s M ) and the rotational correlation time of the whole molecule (s R ) (70) (71) (72) . In general, the clinically used contrast agents such as Omniscan â display slow water exchange rate (long s M ) and fast molecular tumbling (short s R ) due to their low-molecular-weight nature (73) . The rotational time can be changed by increasing the molecular weight of whole molecule by conjugation of complex to a macromolecule (74) (75) (76) . Meanwhile, conjugates with higher molecular weight could show much lower relaxivity than expected due to the local movements inducing a shortening of s R value. These local movements can be slowed down by rigidifying the spacer between the contrast agents and macromolecule (77) (78) (79) . DOTA derivatives, where the amide oxygen atom forms a 6-membered chelate ring upon coordination of Gd(III), were found to have a mean water residency time, which is within the ideal range required for our purposes. The longitudinal relaxation rate (1/T 1 ) of conjugate 8 was measured in water at various Gd 3+ concentrations (0.05, 0.10, 0.20, 0.40, 0.80 and 1.60 mM) and is clearly concentration dependant, as can be observed on T 1 -weighted MR images (Fig. 5) where the more prominent positive contrast is achieved for compound 8 the higher concentration.
T 1 relaxivity (r 1 ), was then determined from the slope of 1/T 1 versus [Gd 3+ ] plot (Fig. 6) . r 1 values of compound 8 then calculated to be 1.43 mM À1 s À1 (Table 3) . Conjugate 8 exhibited r 1 relaxivity that was compared to the values available for Gd-595 (7) and Omniscan â (Table 3) , and exhibited close but weaker values, confirming that the conjugate 8 retains the contrast imaging property of the Gd-DOTA moiety. The weaker values may be attributed to the amide function on the spacer arm, likely to block the water-binding site. 
In vitro compatibility assessments
In order to analyze biocompatibility, cell viability in the absence of light was investigated, to assess the relevance of the use of conjugate 8 as a theranostic agent: a photosensitizer should actually not be toxic at the working concentrations in the absence of light. Human breast adenocarcinoma cells (MCF-7) were treated with conjugate 8 in final concentrations of 1, 5, 10, 20 and 50 lM, 24 h after cell seeding (n = 4). After 24, 48 and 72 h of incubation, viability of cells was evaluated by Alamar blue assay. Nontreated cells were used as control group and the viability of treated cells are shown relative to nontreated cells in Fig. 7 . At 24 h, conjugate 8 caused no adverse effects on viability of cells when used between 1-20 lM of concentration. However, treatment with 50 lM of conjugate 8 decreased cell viability to~75%. Longer exposure times (48 and 72 h) induce an antiproliferative effect on MCF-7 cells for 20 lM of conjugate 8, which remains not toxic at 1-10 lM, these concentrations causing no significant effect on cell proliferation (Fig. 7) . The cell uptake of conjugate 8 by MCF-7 cells was investigated as well. Cells were seeded in 24-well plates at a density of 5 9 10 3 cells/well. After a 24 h incubation period, the cells were treated with 10 lM of conjugate 8 at 37°C for 24 h in a humidified incubator. The samples were analyzed with Zeiss LSM-510 confocal microscope with an oil-immersion 639 objective lens. An argon laser of 488 nm wavelength was used. The uptake of conjugate 8 is evidenced in Fig. 8 . Further subcellular localization assays by colocalization with nuclear stains are being conducted to precisely assess the distribution of conjugate 8.
These preliminary data demonstrate the suitability of conjugate 8 for further biological investigations, currently ongoing.
CONCLUSION
A novel type of theranostic combining MRI contrast imaging and photodynamic properties has been designed and successfully synthesized. A phthalocyanine was selected for the photodynamic ability, in which a Gd-DOTA moiety was introduced to add MRI contrast imaging properties. The works presented here demonstrated the relevance of this design, as the conjugate retains the photophysical and photochemical properties of the phthalocyanine core: the singlet oxygen generation of the conjugate is in the same range as the reference without DOTA moiety. Even though the MRI contrast imaging ability of the conjugate is lowered compared to related commercial Gd complexes, the data obtained are suitable for imaging purposes. In vitro assays indicate an appropriate innocuousness of the conjugate at concentrations used for treatment. All these measurements together confirm the relevance of this new theranostic concept. Further biological investigations are in progress.
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